Amylyx appoints Karen Firestone to board of directors, effective March 16, 2023

Amylyx Pharmaceuticals, Inc.

Karen Firestone appointed as Class I director effective March 16, 2023.
Will serve on Audit Committee and Nominating and Corporate Governance Committee.
Eligible for annual cash retainer of $45,000 plus committee retainer fees.
Granted initial option for 27,403 shares; one-third vests in 1 year, balance over 2 years.
Director compensation policy amended January 20, 2023, filed as exhibit.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Karen Firestone

Director

AMLX · Amylyx Pharmaceuticals, Inc.

Effective: 2023-03-16
Filed: March 21, 2023, 7:59 PM ET

appointed Karen Firestone to fill the vacancy on the Board as a Class I director, effective as of March 16, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Karen Firestone was appointed as Director at Amylyx Pharmaceuticals, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Karen Firestone to fill the vacancy on the Board as a Class I director, effective as of March 16, 2023

View on SEC.gov

Amylyx Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-075821

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.